TAVI – Is Lifetime Patient Management the Alpha to Omega of Contemporary Practice?

Published: 20 March 2024

  • Views:

    Views Icon 2086
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

This symposium hosted at Transcatheter Interventions Online 2024 explored cutting-edge advancements in coronary access and valve design within TAVI. The faculty analysed factors affecting coronary access across diverse valve designs and strategies to enhance access. This session provides step-by-step techniques for achieving optimal implant depth and implements guidelines for procedural confirmation in TAVI.

This symposium is supported by an unrestricted educational grant by Boston Scientific.

Learning objectives

  • Evaluate the factors influencing coronary access in different valve designs
  • Formulate strategies to optimise coronary access based on valve characteristics
  • Evaluate the role of valve design in reducing pacemaker implantation rates and enhancing future coronary access
  • Learn the step-by-step process for achieving optimum implant depth during TAVI
  • Apply guidelines and best practices for achieving and confirming optimum implant depth in TAVI procedures

Target Audience

  • Interventional Cardiologists
  • Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
  • Interventional Cardiology Nurses

More from this programme

Part 1

Welcome & Case Outline

Part 2

Considerations for TAVI Choice in Younger Patients

Part 3

Getting Optimum Implant Depth – Step-by-Step Guide

Part 4

Live Case and Panel Discussion

Faculty Biographies

Verena Veulemans

Verena Veulemans

Interventional cardiologist

Verena Veulemans is an interventional cardiologist at University Hospital Düsseldorf, Germany. She joined the TAVR team in 2012 and has been a senior consultant since 2017. Dr Veulemans has led the interventional and transcatheter valve implantation/aortic disease research programme since 2018. She participates in many multicentre, international registries, and studies on TAVR and structural heart disease.

Dr Veulemans is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3) since March 2021. 

View full profile

Comments

You must be to comment. If you are not registered, you can register here.